These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: XTL Biopharmaceuticals (XTLB), 14,267% surge in interest Hoth Therapeutics
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: XTL Biopharmaceuticals (XTLB), 14,267% surge in interest Hoth Therapeutics
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Hoth Therapeutics (HOTH), 3,975% surge in interest ChromaDex (CDXC),
Atreca (BCEL) is scheduled to report 4th quarter earnings on 03/13/2024. Regarding Q4 estimates, Wall Street analysts expect Atreca to post earnings of -$0.35 per share. Last quarter, Atreca missed
Atreca Inc (BCEL) has released an update to notify the public and investors about its officers. As Atreca, Inc. scales down operations, Dr. Tito A. Serafini and Dr. Stephen E.
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Milestone Pharmaceuticals (MIST), 2,418% surge in interest Coherus Bio